It is now well established that intermolecular associations are essential for the generation of intracellular signals resulting from receptor occupancy. In recent years a number of modular domains have been identified which mediate such interactions, and examples include SH2 1 and SH3 domains, originally identified as noncatalytic regions of homology to the v-src oncogene (1, 2). SH2 domains bind to specific phosphotyrosine-containing peptide sequences, commonly in transmembrane receptors, and the specificity of this interaction is determined mainly by the residues immediately flanking the phosphorylated tyrosine residue (3-8). SH2 domains all consist of two antiparallel ␤ sheets surrounded by two ␣-helices, with the phosphotyrosine and ϩ3 residue tightly bound to two pockets on the domain surface (9).
It is now well established that intermolecular associations are essential for the generation of intracellular signals resulting from receptor occupancy. In recent years a number of modular domains have been identified which mediate such interactions, and examples include SH2 1 and SH3 domains, originally identified as noncatalytic regions of homology to the v-src oncogene (1, 2) . SH2 domains bind to specific phosphotyrosine-containing peptide sequences, commonly in transmembrane receptors, and the specificity of this interaction is determined mainly by the residues immediately flanking the phosphorylated tyrosine residue (3) (4) (5) (6) (7) (8) . SH2 domains all consist of two antiparallel ␤ sheets surrounded by two ␣-helices, with the phosphotyrosine and ϩ3 residue tightly bound to two pockets on the domain surface (9) .
SH3 domains are regions of about 50 -75 amino acids, which are commonly found in signaling molecules, in cytoskeletal components, and also in the phagocyte superoxide-forming complex, NADPH oxidase (1, 2) . SH3 domains bind to prolinerich sequences with a core motif of PXXP where P are conserved proline residues and X are commonly aliphatic residues; however, the structural basis for the specificity of SH3-ligand interactions is less well understood compared to SH2 domains (10) . Although there is some promiscuity in the binding of some SH3 domains to different proline-rich motifs (11) , other SH3 domains are highly selective and will bind to only a single specific sequence (12) . All SH3 domain ligands adopt a type II polyproline helix conformation, and structural studies have shown that proline-rich motifs fall into two classes, which can bind to SH3 domains in either forward or reverse orientations (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . In phagocytes the activation of the NADPH oxidase is absolutely dependent on the regulated interaction of SH3 domain-containing components, yet the mechanism by which binding is initiated and regulated is not understood (25) . In an attempt to identify novel SH3-binding proteins that might be involved in intracellular signaling in the hematopoietic cells, we have identified the product of the gene responsible for Wiskott-Aldrich syndrome (WASP) (26) as a protein that binds to a subset of SH3 domains, and we have characterized the sequences on the WASP protein responsible for SH3 domain binding.
EXPERIMENTAL PROCEDURES
Cells and Reagents-The bacterial expression vector pGEX-4T-1 was purchased from Pharmacia Biotech Inc. Glutathione-agarose beads were obtained from Sigma. Namalwa cells were originally obtained from the American Type Culture Collection and cultured in RPMI 1640 medium (Flow Laboratories) containing 10% heat-inactivated fetal calf serum (Imperial Laboratories) at 37°C in 5% CO 2 . Synthetic peptides with free charged termini were synthesized by Zinsser (Maidenhead, United Kingdom) using Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry and were Ͼ80% pure as assessed by HPLC and mass spectrometry. All chemicals were Analar grade or better (BDH), and all other reagents were purchased from Sigma unless stated otherwise.
Glutathione S-Transferase Fusion Proteins-cDNA sequence encoding the SH3 domains of PLC␥1, p85␣, c-Src, n-Src, c-Fgr, p47 phox , and p67 phox as glutathione S-transferase (GST) fusion proteins were generated and used as described previously (11, 12) . Constructs were transformed into Escherichia coli XL1-Blue and expression of GST fusion proteins performed as described previously (12, 27) .
GST-SH3 Binding Assays-Affinity matrices were prepared by immobilizing 25 g of fusion protein on 50 l of glutathione-agarose beads (Sigma). Cells were pelleted and washed twice in phosphate-buffered saline. Cell pellets were solubilized in lysis buffer (50 mM Tris, pH 7.5, 5 mM EGTA, 2% (v/v) Triton X-100, 75 mM NaCl, 0.5 mM phenylmethanesulfonyl fluoride) and clarified by centrifugation at 14,000 ϫ g for 15 min at 4°C. Cell lysate was mixed with the GST-SH3 affinity matrices for 3 h at 4°C. The beads were then washed extensively in wash buffer * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. (50 mM Tris, pH 7.5, 0.1% (v/v) Triton X-100, 10% (v/v) glycerol). Binding proteins were eluted by boiling in SDS-PAGE sample buffer, resolved by SDS-PAGE, and prepared for microsequencing or transferred to nitrocellulose filters for immunoblotting. In experiments to investigate the ability of peptides to inhibit WASP-SH3 domain interaction, binding was performed in the presence of the synthetic peptide at the indicated concentration.
Sequencing of 55-60-kDa SH3 Domain-binding Protein-A 55-60-kDa polypeptide that bound to the SH3 domain of PLC␥1 was purified from 10 9 Namalwa cells by SH3 affinity chromatography as described above. The protein sample was separated by SDS-PAGE, identified by Coomassie Blue staining, excised, and digested with Lys-C in the gel slice. Peptides were extracted from the gel and separated by tandem ion exchange and reverse phase HPLC using a Hewlett-Packard 1090M and diode array detection system. Purified peptides were sequenced using fast cycle, automated Edman chemistry on an Applied Biosystems 477A sequencer, modified as described (28) .
Western Blotting-Monoclonal antibody 3F3.A5 against a FLAG-WASP fusion protein was generated (29) and used for Western blotting of WASP. SH3 domain-binding proteins were separated by SDS-PAGE, transferred to nitrocellulose filters, and after blocking with 5% nonfat milk powder the filters were overlaid with a 1:1000 dilution of monoclonal anti-WASP in phosphate-buffered saline containing 0.05% Tween 20. The filters were washed three times in phosphate-buffered saline/Tween 20, and the bands were detected using the ECL system (Amersham). Images were scanned using a Microtek Scanmaker II, densitometry was performed, and peaks integrated using ScanAnalysis linked to an Apple Macintosh Quadra.
RESULTS

Identification of a 55-kDa SH3-binding Protein as WASP-
Namalwa cells were lysed into Triton X-100-containing buffer, and after centrifugation of insoluble material the lysates were incubated with GST-SH3 domain fusion proteins. Fig. 1 shows the profile of Namalwa cell proteins associating with the SH3 domain of PLC␥1. In addition to bands at 150 kDa and 100 kDa, a prominent band was detected at 55-60 kDa, which specifically interacted with the immobilized SH3 domain fusion protein (asterisk). This protein was not present when the cell lysate was incubated with beads alone or GST-immobilized beads. Larger quantities of the 55-60-kDa band were prepared from 10 9 cells and purified by incubation with immobilized PLC␥1 SH3 domain followed by SDS-PAGE. The band was excised and subjected to microsequencing as described under "Experimental Procedures." Two peptides were obtained, and sequences derived from these peptides were found to have 100% identity with residues 237-245 and residues 270 -288 of the published sequence of the human Wiskott-Aldrich syndrome protein (WASP) (Fig. 2) . Western blotting of whole cell lysates using a monoclonal against WASP (29) confirmed its presence in the Namalwa cells (data not shown).
Selectivity of WASP-SH3 Domain Associations-The interaction of WASP with a panel of immobilized SH3 domains was examined by immunoblotting (Fig. 3) . WASP was present in affinity precipitates from the SH3 domains of c-Src, p85␣, PLC␥1, and c-Fgr. Significantly less WASP was detected in affinity precipitates using the N-terminal SH3 domain and the tandem SH3 domains of p47 phox . No WASP was detected when the SH3 domains derived from n-Src, the C-terminal SH3 domain of p47 phox , or either the N-terminal or C-terminal domains of p67 phox were used as affinity matrices. The association of WASP with these SH3 domains is likely to be due to direct binding, since baculovirus-expressed WASP shows a similar SH3 domain interaction profile, and the direct association of the WASP proline-rich domain with these SH3 domains can be demonstrated using a yeast two hybrid assay system. 2 We have shown that Sam68 interacts equally efficiently with the SH3 domains of c-Src, p85␣, p47N, and p47N/C but less well with c-Fgr (30) , and that p47 phox interacts with the p67C SH3 domain (12) . Since several of the recombinant SH3 domains that are negative or substantially reduced for WASP association have functional activity in associating with these other prolinerich-motifs, lack of WASP association cannot be due to incorrect folding of the negative SH3 domains.
Characterization of the Motifs in WASP Responsible for the Association with SH3 Domains-The primary sequence of WASP contains multiple potential SH3 binding motifs. In order to identify which of these motifs are responsible for its ability to interact with SH3 domains, peptides corresponding to the WASP proline-rich motifs were prepared. The ability of these peptides to inhibit the interaction of WASP with the SH3 domains of PLC␥1, p85␣, c-Fgr, and c-Src was investigated. At 500 M, peptides 1, 2, and 3 inhibited the association of Namalwa cell-derived WASP with the SH3 domains of c-Fgr, c-Src, 2 C. Soames and L. Wilson, manuscript in preparation. and PLC␥1. In contrast peptides 4, 5, 6, and 7 had no effect on the ability of WASP to associate with any of these SH3 domains (Fig. 4) . None of the peptides tested showed any inhibitory activity against WASP-p85␣ SH3 domain association, suggesting that the interaction of WASP with this SH3 domain was mechanistically different from that of the other SH3 domains. The sequence requirements for inhibitory activity were further investigated using peptides with single amino acid changes. Replacing Arg 309 or Arg 321 with lysine had little effect on the ability of peptide 1 to inhibit association with the SH3 domains of Src, Fgr, or PLC␥1. However replacement of Arg 377 with a lysine in peptide 2 resulted in a significant loss of inhibitory activity for PLC␥1, c-Src, and Fgr SH3 domains (Table I) .
Inhibitory Activities of WASP-derived Peptides-The concentration dependence of the abilities of peptides 1, 2, and 3 to inhibit WASP-SH3 domain interactions was investigated. Cell lysates were incubated with immobilized SH3 domains in the presence of 0 -250 M concentrations of peptide and WASP association was detected by Western blotting. Each of the peptides exhibited rather a sharp concentration dependence (Fig.  5) . The peptides had no effect on the ability of WASP to associate the SH3 domains of either c-Src or PLC␥1 at or below 100 M, except for peptide 1, which showed a slight but consistent inhibitory activity on c-Src association at this concentration. All peptides exhibited greater than 80% inhibitory activity at 250 M.
DISCUSSION
When the SH3 domain of PLC␥1 was used as an affinity matrix for Namalwa B cell lysates, an associated 55-60-kDa protein was identified as WASP, the product of the gene defective in Wiskott-Aldrich syndrome. Recently WASP has been shown to be an effector for the small GTP-binding protein Cdc42H, and it appears to regulate actin polymerization (37) , consistent with the observations that leucocytes from WiskottAldrich patients have fewer surface microvilli (38) . There is a high degree of homology between human and mouse WASP, suggesting evolutionary conservation of function (39) . WiskottAldrich syndrome is an X-linked recessive disorder characterized by severe thrombocytopenia, small platelets, excessive bleeding, eczema, recurrent microbial and viral infections, impaired humoral and cellular immunity, and increased susceptibility to lymphoid malignancies (31) (32) (33) (34) (35) (36) . X-linked congenital thrombocytopenia is also caused by mutations in the WiskottAldrich syndrome gene (40) , and the results reported here that WASP interacts with the SH3 domains from a number of signaling molecules found in leucocytes and platelets are consistent with a conserved role in intracellular signaling.
We have shown that WASP can be isolated using immobilized SH3 domains of PLC␥1, c-Src, c-Fgr, and p85␣, and to a lesser extent using the tandem SH3 domains of p47
phox . Recently it has been reported that WASP will also bind to the SH3 
TABLE I Inhibitory activities of modified WASP-derived proline-rich sequences
Blots were quantitated by densitometry and categorized as follows: ϩϩϩ, Ͼ90% inhibition; ϩϩ, 50 -90% inhibition; ϩ, 10 -50% inhibition; Ϫ, Ͻ10% inhibition. domain of Nck, although the binding motif was not identified (41) . Peptide inhibition experiments revealed sequences on WASP that are responsible for its association with c-Src, c-Fgr, and PLC␥1 SH3 domains. These regions correspond to residues 307-322 (peptide 1), 375-388 (peptide 2), and 336 -349 (peptide 3), and these appear to be approximately equally effective for these SH3 domains. As expected, peptide 7, which does not have a PXXP motif, was inactive, and other WASP-based peptides also showed no activity; therefore, its association with SH3 domains appears to be directed by discrete regions of the protein. None of these peptides inhibited the association of WASP with p85␣ SH3 domain, and so this association may be mediated by another region of the WASP molecule. It is possible that WASP peptides have a lower affinity for SH3 domains relative to whole WASP protein, as has been observed for the Nef protein interacting with the Hck SH3 domain (42) . Peptides also have a lower PPII conformation in solution (43) , and these factors might explain the sharp slope and high concentrations of WASP peptides necessary for inhibition. We found no loss of activity if peptides 1 or 2 were preincubated with cell lysate for 3 h, so degradation by cellular enzymes appeared not to be a significant factor. WASP Peptides 2 and 3 have high homology with a consensus of GRSGPLPPZPZG where Z is a hydrophobic residue, and whilst some homology is lost when peptide 1 is compared, all three peptides have a consensus of ..XRBXPLPPZPZ.. where X is any residue and B is an uncharged residue. These sequences do not fit perfectly within the consensus sequences of RXLPPZP (Class I) or XPPLPXR (Class II) Src SH3 binding motifs as identified by Feng et al. (18) ; however, all three peptides have an arginine residue N-terminal to the PXXP sequence, which is common on Class I ligands (17) (18) (19) (20) (21) (22) . In addition peptide 1 also has an arginine C terminus to the PXXP sequence, consistent with Class I ligands (Table  II) . Indeed, comparison of the WASP peptides with several peptides known to be Class I or Class II Src SH3 domainbinding proteins show some degree of homology (Table II) . WASP peptides 1, 2, and 3 have a conserved arginine and proline spacings with Class I Src-binding peptides derived from heteroribonucleoprotein K, p62, and p85␣. Peptide 1 also has proline spacings and an arginine residue conserved in the Class II binding peptides derived from dynamin, heteroribonucleoprotein K, p62, Shb, p85␣, and p47
phox (11, 12, (43) (44) (45) (46) (47) . Thus peptides 1, 2, and 3 are all potentially Class I Src binding motifs, but in addition peptide 1 is also potentially a Class II Src binding motif, despite not conforming exactly to the published consensus sequences. The sequence requirements for inhibitory activity were also examined and substitution of Arg 309 or Arg 321 in peptide 1 for Lys had little effect, indicating that a positively charged amino acid in these positions is sufficient for activity. In contrast, replacement of Arg 377 in peptide 2 with Lys virtually abolished activity, indicating a preferential requirement for arginine in this position.
To date there have been no published clinical mutations in the SH3 domain-binding regions of WASP described here in Wiskott-Aldrich syndrome patients. One patient, however, has an insertion-deletion pair in the cDNA sequence coding for the amino acids between peptides 1 and 3, changing the sequence from 328 RPPIV 332 to PAPYC. An Epstein-Barr virus-transformed cell line from this patient produces normal amounts of a normal size protein, suggesting that this region is essential for WASP function (29) . It is possible that this mutation might interfere with the SH3 domain binding to the WASP prolinerich regions described here, since regions outside the prolinerich core have been shown to be important for the specificity and affinity of Nef for the Fyn SH3 domain (48) .
The specific role of WASP within the cell is at present unknown. The data presented in this paper show that WASP interacts with the SH3 domains of selected signaling molecules, suggesting it might regulate intracellular signaling in addition to associating with the small GTP-binding protein Cdc42 in vitro (37, 49, 50) . WASP appears to be a member of a larger family of proteins, which includes the profilin-binding vasodilator-stimulated phosphoprotein (VASP) (51, 52) , and so WASP might provide a link between SH3 domain-containing signaling molecules such as tyrosine kinases or phospholipases, small GTP-binding proteins, and the cytoskeleton in hematopoietic cells. Further characterization of its intracellular associations will help elucidate WASP function. 
